全文获取类型
收费全文 | 116782篇 |
免费 | 9889篇 |
国内免费 | 6853篇 |
专业分类
耳鼻咽喉 | 1278篇 |
儿科学 | 1680篇 |
妇产科学 | 830篇 |
基础医学 | 10754篇 |
口腔科学 | 1967篇 |
临床医学 | 12553篇 |
内科学 | 16560篇 |
皮肤病学 | 1399篇 |
神经病学 | 5603篇 |
特种医学 | 4858篇 |
外国民族医学 | 25篇 |
外科学 | 13282篇 |
综合类 | 23571篇 |
现状与发展 | 28篇 |
一般理论 | 10篇 |
预防医学 | 10044篇 |
眼科学 | 2128篇 |
药学 | 11727篇 |
112篇 | |
中国医学 | 6726篇 |
肿瘤学 | 8389篇 |
出版年
2024年 | 336篇 |
2023年 | 1187篇 |
2022年 | 3158篇 |
2021年 | 4624篇 |
2020年 | 3468篇 |
2019年 | 2805篇 |
2018年 | 2987篇 |
2017年 | 3227篇 |
2016年 | 3166篇 |
2015年 | 4921篇 |
2014年 | 6271篇 |
2013年 | 6630篇 |
2012年 | 9814篇 |
2011年 | 10590篇 |
2010年 | 8366篇 |
2009年 | 7119篇 |
2008年 | 8192篇 |
2007年 | 8402篇 |
2006年 | 7451篇 |
2005年 | 6595篇 |
2004年 | 5062篇 |
2003年 | 4765篇 |
2002年 | 4000篇 |
2001年 | 2484篇 |
2000年 | 1921篇 |
1999年 | 1256篇 |
1998年 | 845篇 |
1997年 | 824篇 |
1996年 | 537篇 |
1995年 | 507篇 |
1994年 | 414篇 |
1993年 | 259篇 |
1992年 | 212篇 |
1991年 | 182篇 |
1990年 | 132篇 |
1989年 | 113篇 |
1988年 | 97篇 |
1987年 | 83篇 |
1986年 | 86篇 |
1985年 | 46篇 |
1984年 | 50篇 |
1983年 | 31篇 |
1982年 | 32篇 |
1981年 | 27篇 |
1980年 | 26篇 |
1979年 | 16篇 |
1978年 | 22篇 |
1975年 | 21篇 |
1973年 | 19篇 |
1972年 | 21篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
82.
OBJECTIVE: To optimize the process of extracting flavonoids from Smilax glabra. METHODS: Flavonoids were extracted from Smilax glabra by microwave-assisted method, and the extracting time, microwave power, ethanol concentration, solid-solvent ratio and extracting temperature were optimized through single factor experiment and orthogonal test. RESULTS: The optimun process parameters of extracting flavonoids were as follows: the extracting time, microwave power, ethanol concentration, solid-liquid ratio and extracting temperature were 5 minutes, 600 W, 60%, 1:30 and 80 degrees C, respectively. CONCLUSION: The proposed method has been applied stably and reliably to the extraction of flavonoids from Smilax glabra which has the advantages of high recovery and short extraction time. The recovery, the yield and the content of falvonoids are 93.2%, 2.66% and 32.6%, respectively. 相似文献
83.
84.
85.
Amyloidosis is a systemic disease that usually occurs in the gastrointestinal tract or in muscular or adipose tissue. Primary amyloidosis of the urinary bladder is a rare disease that can mimic bladder cancer on cystoscopic examination as well as in its clinical presentation of painless gross hematuria. This report describes a 49-year-old male with repeated painless gross hematuria, who underwent transurethral resection of a suspected bladder tumor. Pathologic examination revealed papillary urothelial hyperplasia with vascular ectasia and no signs of malignancy. Massive gross hematuria occurred 2.5 years later. Cystoscopy showed multiple papillary lesions with yellowish-brown submucosal plaques on the posterior bladder wall. A second transurethral tumor resection was performed and histologic examination revealed plasma cell infiltration and eosinophilic amorphous deposits in the subepithelial stroma and vascular wall. The deposits were positive for Congo red and apple-green birefringence under polarized light examination but negative for Masson's trichrome stain, indicating that they were not fibrotic in nature. Hence, the diagnosis of amyloidosis of the urinary bladder was confirmed. Screening for amyloidosis was negative in other organ systems and the patient has remained disease-free up to the last follow-up 4 years after the second transurethral resection. Amyloidosis should be considered in the differential diagnosis of patients with recurrent hematuria who have symptoms characteristic of bladder cancer but negative pathologic study for malignancy. Correct diagnosis relies on clinical alertness and the use of a special staining technique during pathologic examination. 相似文献
86.
Objective To investigate the effects of intensive insulin therapy on inflammatory re-sponse and prognosis of patients with severe trauma. Methods Eighty severely injured patients were di-vided into intensive insulin therapy group (n = 40, IT) and routine therapy group (n = 40, RT) in random pair. At the time of admission, a continuous infusion of insulin (2 -4 U/h) was pumped into the patients of IT group to maintain blood glucose level at 6 -8 mmol/L. Patients in RT group were given routine treatment without administration of insulin. Fever, organ injury, and mortality of patients in 2 groups were recorded. Venous blood was drawn from patients of 2 groups on the morning of post treatment day (PTD) 1, 3, 5, and 7. Values of TNF-α, C-reactive protein (CRP), IL-2, and IL-10 in plasma were assayed. Results High fever appeared in 9 patients in IT group, and WBC exceeded 10.0×109 for more than 3 days in 17 patients in this group, versus 20 and 29 patients respectively in RT group. Dysfunction of 1 organ appeared in 31 pa-tients in IT group and 30 patients in RT group. Dysfunction of 3 organs appeared in 10 patients in IT group and 19 patients in RT group. Dysfunction of 4 organs appeared in 7 patients in IT group and 12 patients in RT group. In IT group, 4 patients died within 3 post-injury day (PID), and 1 patient died after PID 3 (total case fatality: 12.5% ). In RT group, 5 patients died within 3 PID, and 4 patient died after PID 3 (total case fatality: 22.5%). Plasma levels of TNF-α and CRP of patients in IT group were significantly lower than those of patients in RT group on PID 3 - 7 ( P<0.05 or P<0.01 ), while levels of IL-2 and IL-10 of patients in IT group were significantly higher than those of patients in RT group ( P<0.05 or P<0.01 ). Plasma levels of TNF-α ( 1.3±0.6 μg/L) and CRP (55±16 mg/L) of patients in IT group on PTD 7 were lowered to the trough level, and they were significantly lower than those of patients in RT group (3.0±0.8μg/L, 89±20 mg/L, respectively, P <0.01 ). Conclusions Intensive insulin therapy can mitigate systemic inflammatory response and improve prognosis of patients with severe trauma. 相似文献
87.
关节镜下应用“微骨折”方法修复关节软骨缺损 总被引:3,自引:3,他引:0
目的:探讨关节镜下应用“微骨折”技术对膝关节全层关节软骨缺损修复的效果。方法:对68例全层关节软骨缺损患者进行随机分组:实验组(35例),男17例,女18例,平均年龄35.1岁,采用关节清理后应用“微骨折”技术进行处理,即利用骨刀设计的特性和适度的锤击力量造成软骨下的骨组织微小骨折,刺激软骨生长。对照组(33例),男17例,女16例,平均年龄31.6岁,仅作关节清理术。结果:术后随访6~18个月,平均8.6个月,按Lysholm评分标准,实验组明显优于对照组(P<0.01)。结论:关节镜下应用“微骨折”技术能够显著减轻关节疼痛,增加关节活动度,改善关节功能,是一种简单有效的修复全层关节软骨缺损方法。 相似文献
88.
移情对建立新型医患关系伦理模式的利与弊 总被引:1,自引:0,他引:1
在现代社会这样一个转轨时期,医患矛盾越来越突出,如何缓和医患关系、建立新型医患关系伦理模式成为大家共同关心的课题。作者从移情的角度入手,阐述了新型医患关系伦理模式的内涵,分析了移情对于缓和医患关系有哪些有利之处与不利之处,并提出了如何适度利用移情的方法,使其发挥最大作用。 相似文献
89.
Yanke Yu Wen Zhu Huiling Diao Chunxian Zhou Fanqing F Chen Jun Yang 《Toxicology in vitro》2006,20(6):959-965
Comet assay is a useful technique in the detection of DNA damages, particularly DNA strand breaks; and it has been utilized to show that a potent carcinogen N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), can induce such damages. Recently, gammaH2AX foci formation has been suggested as another sensitive way to detect DNA double strand breaks (DSBs). However, there is no systematic comparison being conducted to evaluate the consistency of these two methods. Using MNNG as a model chemical, the sensitivity of neutral comet assay and gammaH2AX foci formation in detecting MNNG-induced damage was studied. It was found that at concentrations of 0.1 and 1 microg/ml, both methods can detect MNNG-induced damage in human amnion FL cells. However, at 0.1 microg/ml, comet assay revealed more percentage of cells with DNA damage than gammaH2AX fluorescence revealed. On the other hand, while gammaH2AX foci were readily formed at very early times by 10 microg/ml MNNG treatment, neutral comet assay did not detect any significant DNA damage at the same time points. In addition, 10 microg/ml MNNG induced a distinct whole nuclei staining pattern of gammaH2AX, a type of DNA damage which was not detected by neutral comet assay but could be detected by alkaline comet assay. Therefore, gammaH2AX may be used as a sensitive indicator for DNA damage. 相似文献
90.
RNA干扰及其在胶质瘤基因治疗中的应用 总被引:1,自引:0,他引:1
RNA干扰(RNA interference。RNAi)是双链RNA(double—stranded RNA,dsRNA)降解特异性靶基因转录出的mRNA。从而抑制靶蛋白表达的现象。自从二十世纪九十年代发现RNAi这一现象以来,RNAi已被广泛应用于研究基因功能、信号转导通路和基因治疗等方面。随着分子生物学、分子遗传学等学科的发展.发现了许多与肿瘤发生、发展和预后密切相关的基因。经过大量临床前期试验表明,针对特异性靶基因的小干扰RNA(short/small interfering RNA.siRNA)治疗胶质瘤是行之有效的。为基因治疗胶质瘤提供了新的思路。[第一段] 相似文献